Merritronix IPO Final Day: GMP ₹87

Welcome back to our final update on the Merritronix SME IPO, folks! Today marks the closing day, June 3rd, 2026, and it’s been an interesting journey. We’re here to break down the very latest subscription figures and give you the lowdown on the Grey Market Premium (GMP). As of the close of subscriptions, Merritronix, aiming to list on the BSE SME platform, has seen its subscription numbers finalize. The issue price remains firmly at ₹149 per share, with a lot size of 1000 shares. This IPO, which opened on June 1st, is now in its final moments, and investors have been watching closely.

Subscription Status

Let’s dive straight into the subscription numbers as they stand at the close of Day 3. It’s been a bit of a mixed bag across the board, and frankly, the zero figures across all categories are quite the talking point. We’re seeing 0x subscriptions for Retail, 0x for Non-Institutional Investors (NII), and 0x for Qualified Institutional Buyers (QIB). The total subscription also stands at a flat 0x. Now, this is unusual, especially on the closing day of an SME IPO. Typically, you’d expect to see some activity, even if it’s modest. The lack of subscription across all segments, particularly from retail investors who are usually the first to jump in for SME offerings, could concern potential investors. It might suggest a wait-and-watch approach or perhaps a lack of widespread interest at this current valuation. We’ll need to see if there was a last-minute surge that didn’t reflect in the pre-closing data, but as it stands, it’s not the kind of overwhelming demand we often see for promising SME IPOs.

GMP Update

Moving on to the Grey Market Premium (GMP), the sentiment seems to be holding steady. The current GMP for Merritronix is at ₹87. This is exactly the same as it was yesterday, which means it remained unchanged. For an issue price of ₹149, a GMP of ₹87 suggests a potential listing price of around ₹236 (₹149 + ₹87). This expected listing price represents a healthy premium, which is encouraging. The stability in GMP, despite the subscription numbers, indicates that market makers still believe in the company’s future prospects and its potential to perform well post-listing. However, it’s crucial to remember that GMP is an unofficial indicator and can be volatile. The fact that it hasn’t seen a significant jump or fall is interesting, suggesting a cautious optimism in the market.

Should You Apply?

So, the big question: should you have applied for Merritronix? This is where it gets tricky. On one hand, the GMP is suggesting a decent listing gain, which is always attractive for short-term traders. The expected listing price of ₹236, a significant jump from the issue price, paints a positive picture. However, the subscription numbers are, to put it mildly, perplexing. Zero subscription across all categories on the closing day is highly unusual and warrants caution. It’s not the kind of demand that usually drives an IPO sky-high. Typically, strong subscription numbers, especially from NIIs and QIBs, are a good indicator of institutional confidence. The lack thereof here is a red flag. Investors should consider their risk appetite carefully. If you’re looking for potential listing gains and are comfortable with the risk associated with SME IPOs and unusual subscription patterns, the GMP might tempt you. But if you prefer to see strong demand as a prerequisite for applying, this IPO might not fit your criteria. As always, remember to consult with your SEBI-registered investment advisor before making any investment decisions. You can View Full Merritronix IPO Details on our site to get all the data points.